Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Virostem Biotechnology
Sarıyer, Turkey
C
1-10 Employees
2020
Key takeaway
Virostem specializes in developing Crispr-based gene editing products, highlighting its commitment to scientific innovation and research in areas like genome editing and cellular therapy. Their experienced team and optimized production pipeline ensure high-quality solutions for academic, clinical, and industrial applications.
Reference
Core business
Virostem Biotechnology
Virostem develops and produces Crispr-based gene editing products for academic and clinical research and industrial applications.
NucleoGene Biotechnology
Kartal, Turkey
C
11-50 Employees
-
Key takeaway
Nucleogene is a biotechnology company focused on developing products for medical and industrial use, particularly in clinical diagnostics and research kits. Their dedication to innovative biotechnology methods positions them to address future health and food industry demands.
Reference
Core business
DNA NucleoGene
ELM Genomics
Küçükçekmece, Turkey
C
1-10 Employees
2022
Key takeaway
ELM Genomics is focused on healthcare analytics and offers innovative genomic products, including "İlk-Bakış," a comprehensive newborn genetic screening that identifies 170 actionable diseases. This early detection approach aims to improve outcomes for children with congenital rare diseases, addressing a critical need in precision medicine.
Reference
Core business
ELM Genomics – Healthcare Analytics Company
Healthcare Analytics Company
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Genomize
Turkey
C
11-50 Employees
2014
Key takeaway
Genomize is a biotech startup that specializes in genome-level data analysis, providing clinicians and researchers with insights to improve patient outcomes. Their SEQ Platform offers comprehensive NGS data analysis and accurate classification for variant interpretation, which could be relevant for in vivo gene therapy approaches.
Reference
Core business
Genomize - Turning Genomic Data Into Actionable Insights
From raw data to diagnosis, SEQ Platform provides comprehensive NGS data analysis and accurate ACMG classification for variant interpretation.
Gen Pharmaceuticals
Turkey
C
- Employees
1988
Key takeaway
The company, recognized as one of Turkey's fastest-growing pharmaceutical firms, has initiated a Phase 1 study for its innovative drug SUL-238, which aligns with its commitment to providing cutting-edge therapies for rare diseases and other critical health areas.
Reference
Core business
Gen | Strong Partner, Patient Centric Solutions
Gen - Making a difference with our products in Rare Diseases, Neurology, Pediatrics, Hematology, Oncology, Endocrinology, Nephrology.
VISION BIOTECHNOLOGY
Turkey
C
51-100 Employees
2011
Key takeaway
Vision Biotechnology is focused on developing diagnostic test kits that enhance disease detection through techniques like real-time qPCR, which can amplify and quantify target DNA for rapid results.
Reference
Product
AHG – Vision Biotechnology
Pairend Biyoteknoloji
Üsküdar, Turkey
C
1-10 Employees
2018
Key takeaway
The company highlights its NGS Cloud platform, which enhances genetic diagnostics through advanced data interpretation and a prioritization algorithm. This expertise could be valuable for understanding the genetic aspects of rare diseases, potentially relevant to in vivo gene therapy research.
Reference
Core business
NGS Cloud | Next Generation Genetic Diagnosis Platform
Cytronics
Kestel, Turkey
C
51-100 Employees
2008
Key takeaway
INVAMED is dedicated to continuous innovation in healthcare, developing high-quality medical devices that enhance treatment methods and provide long-term results for patients. Their commitment to R&D suggests a focus on advancing therapeutic solutions, potentially including areas like gene therapy.
Reference
Product
INVAMED Research & Development | Inca Trellis Thrombolysis Systems
Axolotl Biosystems
Esenler, Turkey
C
1-10 Employees
2016
Key takeaway
The company specializes in developing advanced bioprinting platforms for tissue engineering and regenerative medicine, emphasizing the creation of powerful and reliable products that enhance research capabilities.
Reference
Product
AxoMono
Solaris Genomic Health
Turkey
C
1-10 Employees
2021
Key takeaway
Solaris Genomics is dedicated to shaping the future of healthcare by harnessing the potential of genetic data and advanced health technologies. Their focus on personalized health solutions and revolutionary approaches in genomic medicine, including polygenic scoring and genomic testing, aligns with the growing interest in in vivo gene therapy.
Reference
Product
Solutions | Solaris GH
Technologies which have been searched by others and may be interesting for you:
When exploring the In Vivo Gene Therapy industry in Turkey, several key considerations come into play. Regulatory frameworks are crucial, as the Turkish Medicines and Medical Devices Agency (TMMDA) oversees the approval processes for gene therapies, necessitating compliance with both local and international standards. The industry faces challenges such as the need for significant investment in R&D and the complexities of clinical trials, which can be lengthy and resource-intensive. However, opportunities abound, particularly in collaboration with academic institutions and research centers that are increasingly focusing on biotechnological innovations. The competitive landscape is evolving, with both local startups and established international companies vying for market share, which can spur advancements in treatment options. Moreover, Turkey serves as a strategic location for clinical trials due to its diverse patient population and growing healthcare infrastructure. Environmental concerns related to the production and application of gene therapies are also gaining attention, requiring companies to adopt sustainable practices. Lastly, the global market relevance of In Vivo Gene Therapy continues to expand, with Turkey positioning itself as a potential hub for development and commercialization in the region, benefiting from its unique geographic and economic advantages.
Some interesting numbers and facts about your company results for In Vivo Gene Therapy
| Country with most fitting companies | Turkey |
| Amount of fitting manufacturers | 50 |
| Amount of suitable service providers | 29 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1988 |
| Youngest suiting company | 2022 |
Some interesting questions that has been asked about the results you have just received for In Vivo Gene Therapy
What are related technologies to In Vivo Gene Therapy?
Based on our calculations related technologies to In Vivo Gene Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of In Vivo Gene Therapy?
Start-Ups who are working in In Vivo Gene Therapy are ELM Genomics, Solaris Genomic Health
Which industries are mostly working on In Vivo Gene Therapy?
The most represented industries which are working in In Vivo Gene Therapy are Biotechnology, Medical, Healthcare, Pharmaceuticals, IT, Software and Services
How does ensun find these In Vivo Gene Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.